The content of this article is more than 5 years old. Please be aware that information provided may no longer be accurate, up-to-date, or relevant.
Alta Charo testified before the House Energy and Commerce Subcommittee on Health in July regarding proposed legislation to weaken FDA controls over off-label promotion of pharmaceuticals.
Submitted by Law School News on July 12, 2017
This article appears in the categories: Activities & Scholarship
